These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38111613)

  • 1. Effects of elevated emotional symptoms on metabolic disease development: a 10-year follow-up study.
    Sanchez-Carro Y; de la Torre-Luque A; Vassou C; Lopez-Garcia P; Georgousopoulou E; Pitsavos C; Ayuso-Mateos JL; Panagiotakos D
    Front Psychiatry; 2023; 14():1148643. PubMed ID: 38111613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic dysregulation in older adults with depression and loneliness: The ATHLOS study.
    de la Torre-Luque A; Lara E; de la Fuente J; Rico-Uribe LA; Caballero FF; Lopez-Garcia P; Sanchez-Niubo A; Bobak M; Koskinen S; Haro JM; Ayuso-Mateos JL
    Psychoneuroendocrinology; 2021 Jan; 123():104918. PubMed ID: 33113390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of immunometabolic risk factors with symptoms of depression and anxiety: The role of cardiac vagal activity.
    Hu MX; Penninx BWJH; de Geus EJC; Lamers F; Kuan DC; Wright AGC; Marsland AL; Muldoon MF; Manuck SB; Gianaros PJ
    Brain Behav Immun; 2018 Oct; 73():493-503. PubMed ID: 29920329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighing poor immunometabolic health in relatives for severity of affective symptoms: A study of patients with depressive and anxiety disorders and their siblings.
    van Sprang ED; Maciejewski DF; Giltay EJ; Hartman CA; Penninx BWJH; Milaneschi Y
    Psychoneuroendocrinology; 2023 Oct; 156():106326. PubMed ID: 37393801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and depressive symptoms, and stress biomarkers in pregnant women after in vitro fertilization: a prospective cohort study.
    García-Blanco A; Diago V; Hervás D; Ghosn F; Vento M; Cháfer-Pericás C
    Hum Reprod; 2018 Jul; 33(7):1237-1246. PubMed ID: 29796614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and anxiety in patients with diabetes in a Moroccan region.
    Benmaamar S; Lazar N; El Harch I; Maiouak M; Qarmiche N; Otmani N; Salhi H; Tachfouti N; El Ouahabi H; El Fakir S
    Encephale; 2022 Dec; 48(6):601-606. PubMed ID: 34654567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediabetes and the risk of type 2 diabetes: Investigating the roles of depressive and anxiety symptoms in the Lifelines cohort study.
    Deschênes SS; McInerney A; Nearchou F; Byrne B; Nouwen A; Schmitz N
    Diabet Med; 2023 Jul; 40(7):e15061. PubMed ID: 36751973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediabetes, depressive and anxiety symptoms, and risk of type 2 diabetes: A community-based cohort study.
    Deschênes SS; Burns RJ; Graham E; Schmitz N
    J Psychosom Res; 2016 Oct; 89():85-90. PubMed ID: 27663115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of symptoms of anxiety and depression with diabetes and cardiovascular risk factors in older people with intellectual disability.
    de Winter CF; Hermans H; Evenhuis HM; Echteld MA
    J Intellect Disabil Res; 2015 Feb; 59(2):176-85. PubMed ID: 23627768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid depressive and anxiety symptoms and the risk of type 2 diabetes: Findings from the Lifelines Cohort Study.
    Deschênes SS; Burns RJ; Schmitz N
    J Affect Disord; 2018 Oct; 238():24-31. PubMed ID: 29852343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses.
    Peng P; Wang Q; Lang XE; Liu T; Zhang XY
    Front Endocrinol (Lausanne); 2023; 14():1138233. PubMed ID: 36926027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety and Depressive Symptoms as Predictors of All-Cause Mortality among People with Insulin-Naïve Type 2 Diabetes: 17-Year Follow-Up of the Second Nord-Trøndelag Health Survey (HUNT2), Norway.
    Iversen MM; Nefs G; Tell GS; Espehaug B; Midthjell K; Graue M; Pouwer F
    PLoS One; 2016; 11(8):e0160861. PubMed ID: 27537359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
    Gil K; Radziłłowicz P; Zdrojewski T; Pakalska-Korcala A; Chwojnicki K; Piwoński J; Ignaszewska-Wyrzykowska A; Załuga L; Mielczarek M; Landowski J; Wyrzykowski B
    Kardiol Pol; 2006 May; 64(5):464-9. PubMed ID: 16752328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group-Based Trajectory Analysis of Emotional Symptoms Among Survivors After Severe Traumatic Brain Injury.
    Ren D; Fan J; Puccio AM; Okonkwo DO; Beers SR; Conley Y
    J Head Trauma Rehabil; 2017; 32(6):E29-E37. PubMed ID: 28195956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
    Sánchez-Carro Y; de la Torre-Luque A; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Pérez-Solà V; Toll A; Martínez-Ruiz A; Ferreirós-Martínez R; Pérez S; Sastre J; Álvarez P; Soria V; López-García P
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110674. PubMed ID: 36332700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.